Stay updated on Immunotherapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy in NSCLC Clinical Trial page.
Latest updates to the Immunotherapy in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedLocations section reorganized to consolidate all participating sites under a single Locations heading, replacing state-specific headings; the page revision updated to v3.3.3.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision history updated from v3.2.0 to v3.3.2 on the page. Other content appears unchanged.SummaryDifference0.0%
- Check52 days agoChange DetectedRemoval of the government funding status notice from the study page; it does not alter the study details, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check59 days agoChange DetectedThe Taiwan site location was updated from 'Tainan City, Taiwan' to 'Tainan, Taiwan'.SummaryDifference0.1%
- Check66 days agoChange DetectedThe core study details remain unchanged (no modifications to trial arms, eligibility criteria, outcomes, or listed locations); only minor formatting adjustments and timestamp metadata updates were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check95 days agoChange Detected- Added a government funding notice and operating status details (affecting core content and important time-sensitive information). - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%
Stay in the know with updates to Immunotherapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy in NSCLC Clinical Trial page.